Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfuqiangxin pills for chronic heart failure
ChiCTR2000028777Phase 4Not yet recruiting
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences, Fuwai Hospital of Chinese Academy of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of shenfuqiangxin in chronic heart failure (CHF) (2 arms), sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences, Fuwai Hospital of Chinese Academy of Medical Sciences. Primary endpoint: NT-proBNP. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
shenfuqiangxin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR2000028777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028777.